The Baldwin Group, Inc. (BWIN) Insider Trading

Last 12 months

Insiders bought $1M and sold $6.42M on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. See Remarks James Morgan Roche sold $5.74M on Dec 15, 2025, 23% of their stake, outside a plan.

Net open-market

−$5.42M

1 buy · 3 sales

Under a 10b5-1 plan

of the value sold

Insiders who bought / sold

1 / 2

executives and directors

Last open-market buy

Mar 2026

Mar 3, 2026

Get an email when BWIN's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
May 14	Seth Bala Cohen General Counsel	SoldNo plan	15,000	$20.01	$300k	52%	Form 4
May 6 – 7	Elizabeth Krystyn Other	SoldNo plan 4 parts	202,000	$21.19 average	$4.28M	34%	Form 4
Mar 6	Elizabeth Krystyn Other	SoldNo plan 2 parts	119,987	$21.25 average	$2.55M	21%	Form 4
Mar 2 – 3	Paul Eugene Sparks Director	Bought 2 parts	44,200	$22.66 average	$1M	4.1%	Form 4
Dec 11, 2025 – Dec 15, 2025	James Morgan Roche See Remarks	SoldNo plan 4 parts	240,000	$23.93 average	$5.74M	23%	Form 4
Dec 5, 2025	James Morgan Roche See Remarks	SoldNo plan	15,000	$25.08	$376k	1.4%	Form 4
Aug 13, 2025	Seth Bala Cohen General Counsel	SoldNo plan	2,775	$34.00	$94k	21%	Form 4
Aug 7, 2025	Bradford Hale Chief Financial Officer	Bought	10,000	$28.72	$287k	6.9%	Form 4
Jun 12, 2025 – Jun 13, 2025	James Morgan Roche See Remarks	SoldNo plan 2 parts	37,573	$40.06 average	$1.51M	47%	Form 4
Jun 11, 2025 – Jun 12, 2025	Trevor Baldwin Chief Executive Officer	SoldNo plan 3 parts	175,000	$39.38 average	$6.89M	8.1%	Form 4
Jun 9, 2025	Lowry Baldwin Director	SoldNo plan	50,000	$38.98	$1.95M	0.4%	Form 4
Jun 4, 2025	James Morgan Roche See Remarks	SoldNo plan	7,142	$40.08	$286k	8.2%	Form 4
Jun 3, 2025	Seth Bala Cohen General Counsel	SoldNo plan	4,496	$39.58	$178k	25%	Form 4
May 28, 2025	Lowry Baldwin Director	SoldNo plan 2 parts	62,500	$38.32 average	$2.4M	100%	Form 4
May 15, 2025 – May 16, 2025	James Morgan Roche See Remarks	SoldNo plan 2 parts	17,794	$40.02 average	$712k	17%	Form 4
May 8, 2025 – May 13, 2025	James Morgan Roche See Remarks	SoldNo plan 2 parts	34,375	$40.04 average	$1.38M	25%	Form 4
May 13, 2025	Daniel Galbraith See Remarks	SoldNo plan	39,207	$40.00	$1.57M	91%	Form 4
May 12, 2025	Lowry Baldwin Director	SoldNo plan 4 parts	62,500	$39.00 average	$2.44M	0.5%	Form 4
Mar 12, 2025 – Mar 14, 2025	Trevor Baldwin Chief Executive Officer	SoldNo plan 5 parts	136,101	$40.00 average	$5.44M	77%	Form 4
Mar 3, 2025 – Mar 4, 2025	Lowry Baldwin Director	SoldNo plan 5 parts	125,000	$39.56 average	$4.95M	1.0%	Form 4
Feb 27, 2025	Seth Bala Cohen General Counsel	SoldNo plan	12,293	$41.54	$511k	58%	Form 4
Dec 9, 2024 – Dec 11, 2024	Elizabeth Krystyn Other	SoldNo plan 6 parts	423,877	$44.26 average	$18.8M	23%	Form 4

May 14No plan
Seth Bala Cohen
General Counsel · sold 15,000 at $20.01
$300k
52% of stake
May 6 – 7No plan
Elizabeth Krystyn
Other · sold 202,000 at avg $21.19
$4.28M
34% of stake
Mar 6No plan
Elizabeth Krystyn
Other · sold 119,987 at avg $21.25
$2.55M
21% of stake
Mar 2 – 3
Paul Eugene Sparks
Director · bought 44,200 at avg $22.66
$1M
4.1% of stake
Dec 11, 2025 – Dec 15, 2025No plan
James Morgan Roche
See Remarks · sold 240,000 at avg $23.93
$5.74M
23% of stake
Dec 5, 2025No plan
James Morgan Roche
See Remarks · sold 15,000 at $25.08
$376k
1.4% of stake
Aug 13, 2025No plan
Seth Bala Cohen
General Counsel · sold 2,775 at $34.00
$94k
21% of stake
Aug 7, 2025
Bradford Hale
Chief Financial Officer · bought 10,000 at $28.72
$287k
6.9% of stake
Jun 12, 2025 – Jun 13, 2025No plan
James Morgan Roche
See Remarks · sold 37,573 at avg $40.06
$1.51M
47% of stake
Jun 11, 2025 – Jun 12, 2025No plan
Trevor Baldwin
Chief Executive Officer · sold 175,000 at avg $39.38
$6.89M
8.1% of stake
Jun 9, 2025No plan
Lowry Baldwin
Director · sold 50,000 at $38.98
$1.95M
0.4% of stake
Jun 4, 2025No plan
James Morgan Roche
See Remarks · sold 7,142 at $40.08
$286k
8.2% of stake
Jun 3, 2025No plan
Seth Bala Cohen
General Counsel · sold 4,496 at $39.58
$178k
25% of stake
May 28, 2025No plan
Lowry Baldwin
Director · sold 62,500 at avg $38.32
$2.4M
100% of stake
May 15, 2025 – May 16, 2025No plan
James Morgan Roche
See Remarks · sold 17,794 at avg $40.02
$712k
17% of stake
May 8, 2025 – May 13, 2025No plan
James Morgan Roche
See Remarks · sold 34,375 at avg $40.04
$1.38M
25% of stake
May 13, 2025No plan
Daniel Galbraith
See Remarks · sold 39,207 at $40.00
$1.57M
91% of stake
May 12, 2025No plan
Lowry Baldwin
Director · sold 62,500 at avg $39.00
$2.44M
0.5% of stake
Mar 12, 2025 – Mar 14, 2025No plan
Trevor Baldwin
Chief Executive Officer · sold 136,101 at avg $40.00
$5.44M
77% of stake
Mar 3, 2025 – Mar 4, 2025No plan
Lowry Baldwin
Director · sold 125,000 at avg $39.56
$4.95M
1.0% of stake
Feb 27, 2025No plan
Seth Bala Cohen
General Counsel · sold 12,293 at $41.54
$511k
58% of stake
Dec 9, 2024 – Dec 11, 2024No plan
Elizabeth Krystyn
Other · sold 423,877 at avg $44.26
$18.8M
23% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch BWIN, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Insurance Agents, Brokers & Service

SLQTSelectQuote, Inc.

HGTYHagerty, Inc.

CRD-ACrawford & Co

ACTEnact Holdings, Inc.

ARXAccelerant Holdings Ltd

CRVLCorVel Corporation

EHTHeHealth Inc.

GSHDGoosehead Insurance Inc.

Spot a number that looks wrong? Check it in BWIN's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing BWIN

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.